영상 유도 방사선 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Image Guided Radiotherapy Market size is expected to reach USD 5.22 Billion in 2034 from USD 2.68 Billion (2025) growing at a CAGR of 7.69% during 2026-2034.

The Global Image Guided Radiotherapy Market is witnessing strong growth as advanced cancer treatment technologies gain wider adoption. Image-guided radiotherapy (IGRT) is a specialized radiation therapy technique that uses imaging technologies to precisely target tumors during treatment. This approach helps minimize damage to surrounding healthy tissues while improving treatment effectiveness.

Increasing prevalence of cancer and the growing demand for precise and minimally invasive treatment methods are major factors driving market growth. Technological advancements in imaging systems such as CT scans, MRI, and cone-beam imaging are enhancing the accuracy of radiotherapy procedures. Hospitals and cancer treatment centers are increasingly adopting IGRT systems to improve patient outcomes and treatment efficiency.

In the coming years, the Global Image Guided Radiotherapy Market is expected to experience significant expansion as oncology care continues to evolve. Manufacturers are focusing on developing integrated imaging and radiation therapy systems that provide real-time guidance during treatment. With increasing investments in cancer treatment infrastructure and advanced medical technologies, the market is projected to grow substantially.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Radiotherapy/Linac (Linear Accelerators) Devices
• Imaging Devices

By Application

• Breast Cancer
• Lung Cancer
• Brain Tumor
• Prostate Cancer
• Gastrointestinal Cancer
• Gynecological Cancer
• Other Applications

By End-Use

• Hospitals
• Radiotherapy Centers
• Other End-Users

COMPANIES PROFILED

• Accuray Incorporated, CRAD, Elekta, GE Healthcare, Hitachi Ltd, Philips, Siemens Healthineers, Varian Medical Systems Inc, ViewRay Inc, Vision RT Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Radiotherapy/Linac (Linear Accelerators) Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Imaging Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Brain Tumor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Gastrointestinal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Gynecological Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Radiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMAGE GUIDED RADIOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IMAGE GUIDED RADIOTHERAPY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Accuray Incorporated
  • 9.2.2 C-RAD
  • 9.2.3 Elekta
  • 9.2.4 GE Healthcare
  • 9.2.5 Hitachi Ltd
  • 9.2.6 Philips
  • 9.2.7 Siemens Healthineers
  • 9.2.8 Varian Medical Systems Inc
  • 9.2.9 ViewRay Inc
  • 9.2.10 Vision RT Ltd